Erica H. Bell - Concepedia

Author

Erica H. Bell

Also Known As

Bell, E., E. Bell, E. H. Bell, E. Hlavin Bell, E.H. Bell, Erica Bell, Erica H Bell, Erica H. Bell, Erica Hlavin Bell, Patrice Cohen

184

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Arizona Oncology The Ohio State University Wexner Medical Center University of Maryland, Baltimore

About

Erica H. Bell is an author at The Ohio State University specializing in medicine, cell biology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	234
2	Cell Biology	4	4	167
3	Health Sciences	2	2	67
4	Natural Sciences	1	1	53
5	Biochemistry	1	1	53

Erica H. Bell

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma Jan C. Buckner, Edward G. Shaw, Stephanie L. Pugh, New England Journal of Medicine	2016	1K
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma Erica H. Bell, Edward G. Shaw, Jan C. Buckner, Journal of Clinical Oncology	2020	210
Association of<i>MGMT</i>Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide Erica H. Bell, Barbara J. Fisher, David R. Macdonald, JAMA Oncology	2018	198
Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma Fengting Yan, Lapo Alinari, Mark Lustberg, Cancer Research	2014	182
<i>SMARCA4</i> /BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer Erica H. Bell, Arup R. Chakraborty, Xiaokui Mo, Clinical Cancer Research	2015	142
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era Erica H. Bell, Stephanie L. Pugh, Joseph P. McElroy, JAMA Oncology	2017	95
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813 Susan M. Chang, J. Gregory Cairncross, Mark R. Gilbert, Neuro-Oncology	2016	75
Single-Isocenter Multitarget Stereotactic Radiosurgery Is Safe and Effective in the Treatment of Multiple Brain Metastases Joshua D. Palmer, Nikhil Sebastian, Jacquline Chu, Advances in Radiation Oncology	2019	75
miR-15b/16-2 Regulates Factors That Promote p53 Phosphorylation and Augments the DNA Damage Response following Radiation in the Lung Mohammad Aminur Rahman, Francesca Lovat, Giulia Romano, Journal of Biological Chemistry	2014	62
miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma Tiantian Cui, Erica H. Bell, Joseph P. McElroy, Oncogene GliomaMedicineCancer GenomicsNovel OncogeneMicrorna Detection	2018	56

Page 1